EMEA-001758-PIP01-15-M02

  • Email
  • Help

Overview

Product details for -
Invented name-
Active substance

Lumicitabine

Decision numberP/0362/2017
PIP numberEMEA-001758-PIP01-15-M02
Pharmaceutical form(s)Powder for oral suspension
Condition(s)/indication(s)

Treatment of lower respiratory tract disease caused by human respiratory syncytial virus

Route(s) of administrationOral use; Gastric use
PIP applicant

Janssen-Cilag International NV
Tel. +32 14602111
E-mail: contact@janssen-emea.com

Decision typePM: decision on the application for modification of an agreed PIP

Decision